Zobrazeno 1 - 10
of 10
pro vyhledávání: '"L A Bolotskaya"'
Autor:
A T Teplyakov, S D Mayanskaya, L A Bolotskaya, T V Vdovina, T A Stepacheva, A V Kuznetsova, A V Lukinov, N V Derbeneva, M V Frants, S N Shilov
Publikováno v:
Терапевтический архив, Vol 81, Iss 3, Pp 61-68 (2009)
Aim. To evaluate effects of 6-month therapy with losartan in combination with indapamide on a clinical course, immunological, metabolic parameters, left ventricular function, exercise tolerance and quality of life in patients with coronary heart dise
Externí odkaz:
https://doaj.org/article/5b60cec3105d42c4b1d1203a3b80b4c7
Publikováno v:
Терапевтический архив, Vol 80, Iss 12, Pp 44-52 (2008)
Aim. To evaluate clinico-immunological disorders in patients with ischemic heart disease (IHD) and metabolic syndrome (MS), to study an immunocorrective action of nebivolol during 6-month treatment. Material and methods. A total of 54 patients with p
Externí odkaz:
https://doaj.org/article/b8ecab3119db4d70a2f43332862325ea
Autor:
L. L. Bolotskaya
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 132-137 (2020)
Patients with diabetes mellitus (DM 1.2) are at high risk for changing the epidemiological situation during seasonal diseases (influenza, SARS), which mainly occur in the autumn-winter period. Under the current conditions in connection with the pande
Externí odkaz:
https://doaj.org/article/3db7b8b2584e477d8ba80dc47427211f
Publikováno v:
Медицинский совет, Vol 0, Iss 7, Pp 66-71 (2020)
Introduction. The results of a 25-year observational program to assess the effect of glycated hemoglobin variability on the development of microvascular complications in patients with type 1 diabetes mellitus are presented.Objective: This study aimed
Externí odkaz:
https://doaj.org/article/87ecdab203e64e8a94c51448129b9559
Autor:
L. A. Bolotskaya, A. A. Tarlyun
Publikováno v:
Медицинская иммунология, Vol 21, Iss 6, Pp 1055-1062 (2020)
Hormonal and immunological characteristics of have been studied in individuals with initial autoimmune thyroiditis who have first- and second-degree relatives with autoimmune diseases. The age of the studied group of patients was 31±14 years, 60 wom
Externí odkaz:
https://doaj.org/article/6e5a90bef34145e39fd4431feb213709
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 106-111 (2018)
It has been established that during pregnancy women may develop physiological resistance to the action of insulin, which in itself is a risk factor for carbohydrate metabolism disorders. Early diagnosis of hyperglycemia in women at risk for diabetes
Externí odkaz:
https://doaj.org/article/fb276388cabd47bab5a9a1a3d8f1905e
Autor:
Ivan Ivanovich Dedov, E G Bessmertnaya, Larisa Nikankina, A V Ilyin, L L Bolotskaya, M Sh Shamkhalova, I S Glek, A V Zolotukhin, Marina Vladimirovna Shestakova
Publikováno v:
Терапевтический архив, Vol 89, Iss 10, Pp 17-21 (2017)
To assess the time course of changes in the level of glycated hemoglobin (HbA1c) for 20 years after the onset of type 1 diabetes mellitus (T1DM) and to compare its correlation with the development of microvascular complications, such as diabetic reti
Autor:
D. S. Atarshchikov, A. V. Ilyin, N. V. Efremova, O. N. Bondarenko, Marina Vladimirovna Shestakova, L L Bolotskaya
Publikováno v:
Europe PubMed Central
Терапевтический архив, Vol 87, Iss 10, Pp 42-49 (2015)
Терапевтический архив, Vol 87, Iss 10, Pp 42-49 (2015)
To implement in 2009-2012 the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen in patients with type 1 diabetes mellitus (DM) to evaluate the efficiency and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d437c2517cbb9a0113369b957fa2fe56
http://europepmc.org/abstract/med/26978173
http://europepmc.org/abstract/med/26978173
Autor:
L L Bolotskaya, E G Bessmertnaya, M V Shestakova, M Sh Shamkhalova, L V Nikankina, A V Ilyin, I S Glek, A V Zolotukhin, I I Dedov
Publikováno v:
Терапевтический архив, Vol 89, Iss 10, Pp 17-21 (2017)
Aim. To assess the time course of changes in the level of glycated hemoglobin (HbA1c) for 20 years after the onset of type 1 diabetes mellitus (T1DM) and to compare its correlation with the development of microvascular complications, such as diabetic
Externí odkaz:
https://doaj.org/article/9b192e576f1b4bc4bb772602ed17461d
Publikováno v:
Терапевтический архив, Vol 87, Iss 10, Pp 42-49 (2015)
Aim. To implement in 2009—2012 the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen in patients with type 1 diabetes mellitus (DM) to evaluate the efficienc
Externí odkaz:
https://doaj.org/article/ef7d9c95ddd243039e3f28f5fe344458